Publications (247) Armando Torres Ramírez publications

filter_list

2025

  1. Replicating human diabetes: insights from a novel animal model

    American journal of physiology. Endocrinology and metabolism, Vol. 329, Núm. 5, pp. E616-E629

2024

  1. Alteraciones del metabolismo del calcio, del fósforo y del magnesio

    Medicina interna (Elsevier España), pp. 843-851

  2. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia, Vol. 44, Núm. 1, pp. 77-89

  3. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 39-50

  4. Efficacy of the Once-Daily Tacrolimus Formulation LCPT Compared to the Immediate-Release Formulation in Preventing Early Post-Transplant Diabetes in High-Risk Kidney Transplant Patients: A Randomized, Controlled, Open-Label Pilot Study (EUDRACT: 2017-000718-52)

    Journal of Clinical Medicine, Vol. 13, Núm. 24

  5. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 51-60

  6. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome

    Frontiers in Endocrinology, Vol. 15

  7. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  8. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

  9. The error of estimated GFR in predialysis care

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling Overweight/Obese Hypertensive Patients

    Journal of Cardiovascular Development and Disease, Vol. 10, Núm. 7

  2. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia

  3. Exercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study

    Sports Medicine - Open, Vol. 9, Núm. 1

  4. Inflammation on the Waiting List Is a Risk Factor for New-Onset Prediabetes and Post-Transplant Diabetes Mellitus: A Prospective Study

    Nephron, Vol. 147, Núm. 9, pp. 560-571

  5. PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

    Kidney International, Vol. 103, Núm. 1, pp. 207-217

  6. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 6, pp. 1552-1559

  7. Pretransplant evaluation and the risk of glucose metabolic alterations after renal transplantation: a prospective study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 3, pp. 778-786

  8. Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study

    Clinical Kidney Journal, Vol. 16, Núm. 6, pp. 1022-1034

  9. Time-Dependent Changes of Klotho and FGF-23 Levels after Kidney Transplantation: Role of Cold Ischemia Time, Renal Function and Graft Inflammation

    Journal of Clinical Medicine, Vol. 12, Núm. 13

2022

  1. Early glomerular filtration rate changes in living kidney donors and recipients: An example of renal plasticity

    Clinical Kidney Journal, Vol. 15, Núm. 5, pp. 885-894